Company Lookup
عربي
Download Demo
 

Market News

This Month News

This Month News

send to a friend by email

JPH records net income of $1.60 million in Q1 2017

2017-05-02

According to the financial statements of Jerusalem Pharmaceuticals JPH for Q1 2017, Net profit after tax of the period reached 1,605,998 USD Compared with Net Loss after tax (398,776) USD for 2016.Total assets of the company reached 57,266,218 USD compared with total assets of 52,970,017 USD at the end of year 2016, a net increase of 8.11%.Total liabilities of the company reached 13,509,015 USD compared with total liabilities of 12,709,989 USD at the end of year 2016, a net increase of 6.28%. Net ownership equity of the company reached 43,757,203 USD (Including Non-Controlling Interests of 482,438 USD) compared with total owner equity of 40,260,028 USD (Including Non-Controlling Interests of 526,771 USD) at the end of year 2016, a net increase of 8.69%.


 

2021-04-08
QUDS approves distributing 3.50% stocks dividends and 4.50% cash dividends for the year 2020

2021-04-08
TRUST approves distributing 10% cash dividends for the year 2020

2021-04-08
Relative Calmness in the PEX and a momentum in holding the general assembly meetings

2021-04-08
NCI proposes distributing 10% cash dividends for the year 2020

2021-04-08
PEC approves distributing 10% cash dividends for the year 2020

2021-04-04
NIC approves distributing 15% stocks dividends and 22.5% cash dividends for the year 2020

2021-04-01
APIC proposes distributing 9.1476% stocks dividends and 7.50% cash dividends for the year 2020

2021-04-01
Al-Quds Index declines significantly following the dividends’ entitlement of the PEX’s two largest companies

2021-04-01
BOP approves distributing 1% stocks dividends and 4% cash dividends for the year 2020

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013